Vertex today announced positive phase III clinical trial results for VX-770 in cystic fibrosis, a drug that I had previously written about.

I don’t see any point in rehashing the press release, but the data is good news for the company and Cystic Fibrosis patients.

 Vertex announces positive phase 3 data for VX 770 in Cystic Fibrosis

Posted by